Anesthesiology, Pain Medicine · Tulsa, OK
NPI
1346336856
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
4750 S Garnett Rd
Tulsa, OK, 74146
Phone (918) 710-4112
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
68,378 services
Medicare patients, 2024
977
Average age 69
Drug cost, 2024
$947K
16,146 prescriptions
Company payments, 2025
$553
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel G Morris was code J1010 (injection, methylprednisolone acetate, 1 mg), 30,440 times for 208 patients. In total Daniel G Morris billed 68,378 services in 121 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 30,440 | 208 | $0.10 | $3,097 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,969 | 145 | $0.09 | $266 |
| 80307 Drug Tests | Office | 2,633 | 703 | $59.50 | $157K |
| 96127 Behavioral Health Services | Office | 2,430 | 691 | $2.62 | $6,371 |
| J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | Office | 2,370 | 21 | $8.13 | $19K |
| 99213 Office E&M - Established | Office | 2,218 | 703 | $54.29 | $120K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 1,992 | 292 | $0.29 | $572 |
| J2704 Injection, propofol, 10 mg | Office | 1,607 | 118 | $0.08 | $128 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 1,041 | 516 | $193.97 | $202K |
| 99214 Office E&M - Established | Office | 669 | 408 | $73.52 | $49K |
| J0475 Injection, baclofen, 10 mg | Office | 362 | 26 | $135.40 | $49K |
| 62369 Musculoskeletal | Office | 228 | 79 | $57.08 | $13K |
| 85025 Blood Count | Office | 215 | 200 | $7.58 | $1,629 |
| 83036 Blood Count | Office | 212 | 201 | $9.43 | $1,999 |
| 62367 Musculoskeletal | Office | 186 | 58 | $20.32 | $3,779 |
By year: 2022 $716K for 18,560 services; 2023 $1.1M for 48,250 services; 2024 $1.0M for 68,378 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 2,633 | 703 | $59.50 | $157K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,041 | 516 | $193.97 | $202K |
| 85025 Blood Count | 215 | 200 | $7.58 | $1,629 |
| 83036 Blood Count | 212 | 201 | $9.43 | $1,999 |
| 82947 Clinical Chemistry | 183 | 182 | $3.83 | $701 |
| 84132 Clinical Chemistry | 183 | 182 | $4.64 | $849 |
| 82565 Clinical Chemistry | 183 | 182 | $4.99 | $914 |
| 84075 Clinical Chemistry | 183 | 182 | $5.05 | $925 |
| 82310 Clinical Chemistry | 183 | 182 | $5.03 | $921 |
| 82247 Clinical Chemistry | 183 | 182 | $4.90 | $896 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel G Morris prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,230 prescriptions and refills. In total Daniel G Morris wrote 16,146 Medicare prescriptions that cost $947K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,230 | 3,247 | 463 | $96K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,760 | 1,763 | 252 | $56K |
| Gabapentin Generic | 1,264 | 1,398 | 178 | $17K |
| Oxycodone Hcl Generic | 1,039 | 1,039 | 122 | $21K |
| Morphine Sulfate Er Morphine Sulfate | 881 | 881 | 95 | $21K |
| Tizanidine Hcl Generic | 779 | 836 | 110 | $12K |
| Baclofen Generic | 755 | 827 | 127 | $7,891 |
| Pregabalin Generic | 706 | 726 | 96 | $11K |
| Tramadol Hcl Generic | 548 | 548 | 96 | $4,681 |
| Cyclobenzaprine Hcl Generic | 517 | 528 | 82 | $5,648 |
| Morphine Sulfate Generic | 372 | 372 | 57 | $7,763 |
| Tramadol Hcl Er Tramadol Hcl | 341 | 341 | 53 | $17K |
| Buprenorphine Generic | 331 | 331 | 77 | $80K |
| Meloxicam Generic | 266 | 301 | 51 | $882 |
| Levetiracetam Generic | 237 | 303 | 43 | $3,097 |
Brand drugs: - claims; generic drugs: 15,078 claims; opioid claims: 9,643.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel G Morris $553 ($553 in general payments such as food, travel and fees) from 8 companies. The largest payer was Medtronic, Inc. with $321.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 5 | $321 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $70 |
| Saluda Medical Americas, Inc. | 2 | $52.15 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $30.87 |
| Pacira Pharmaceuticals Incorporated PCRX | 1 | $24.84 |
| AppliedVR Inc | 1 | $20.11 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $19.17 |
| Averitas Pharma Inc. | 1 | $15.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.